Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence
Affiliations
Objective: To investigate whether inflammation, oxidation, and tubular injury are present in children with stones (RS) compared with healthy controls (HC) by measuring urinary proteins involved in these processes.
Methods: Quantitative proteomic comparison of pooled urine from RS (N = 30, 24 females, mean age 12.95 ± 4.03 years) versus age- and gender-matched HC (N = 30), using liquid chromatography-mass spectrometry. Relative protein abundance was estimated using spectral counting. Proteins of interest were selected using the following criteria: (1) ≥5 spectral counts; (2) ≥2-fold difference in spectral counts; and (3) P-value ≤.05 for Fisher's exact test.
Results: Of the 1813 proteins identified, 230 met the above criteria, with 163 proteins upregulated in the RS group and 67 upregulated in HC. Functional analysis revealed 19 inflammatory proteins, 5 proteins involved in oxidative stress, and 5 involved in tubular injury. Of those proteins, NADPH-oxidase, a major source of reactive oxygen species, was only found in the RS group, whereas glutathione S-transferase A2, an important antioxidant enzyme, was more abundant in controls. ELISA analysis confirmed statistically significant differences in the urinary excretion of retinol-binding protein 4, a marker of proximal tubular dysfunction, between stone patients with hypercalciuria and controls.
Conclusion: We provide proteomic evidence of oxidative stress, inflammation, and tubular injury in children with renal stones. We speculate that inflammation and changes in the oxidant-antioxidant balance may cause tubular damage in these patients. Targeting these proteins may have therapeutic benefits.
Peerapen P, Thongboonkerd V Biomed J. 2023; 46(2):100577.
PMID: 36642221 PMC: 10267970. DOI: 10.1016/j.bj.2023.01.001.
Matjuda E, Engwa G, Mungamba M, Sewani-Rusike C, Nkeh-Chungag B Pan Afr Med J. 2022; 42:35.
PMID: 35910048 PMC: 9288113. DOI: 10.11604/pamj.2022.42.35.26443.
Urinary proteome in inherited nephrolithiasis.
Capolongo G, Zacchia M, Perna A, Viggiano D, Capasso G Urolithiasis. 2018; 47(1):91-98.
PMID: 30564846 DOI: 10.1007/s00240-018-01104-y.
Urine proteomic profiling in patients with nephrolithiasis and cystinuria.
Kovacevic L, Caruso J, Lu H, Kovacevic N, Lakshmanan Y, Carruthers N Int Urol Nephrol. 2018; 51(4):593-599.
PMID: 30519981 PMC: 6461472. DOI: 10.1007/s11255-018-2044-1.
Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria.
Brooks E, Hoppe B, Milliner D, Salido E, Rim J, Krevitt L Am J Nephrol. 2016; 43(4):293-303.
PMID: 27161247 PMC: 4904731. DOI: 10.1159/000445448.